Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 840863, 6 pages
http://dx.doi.org/10.1155/2014/840863
Research Article

Evaluation the Surface Antigen of the Salmonella typhimurium ATCC 14028 Ghosts Prepared by “SLRP”

1Department of Protein Research, Genetic Engineering and Biotechnology Research Institute, City for Scientific Research and Technology Applications, New Borg Al-Arab, P.O. Box. 21934, Alexandria, Egypt
2Biotechnology Department, Institute of Graduate Studies & Research, Alexandria University, 163 El Horreya Avenu, P.O. Box 832, Alexandria 21526, Egypt
3Zoonoses Research Unit, Faculty of Veterinary Medicine, Alqadisya University, Alqadisya, Iraq
4Department of Clinical Pathology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt

Received 6 January 2014; Accepted 25 February 2014; Published 19 March 2014

Academic Editors: L. Pochini and P. Poltronieri

Copyright © 2014 Amara A. Amro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Muhammad, J. Champeimont, U. B. Mayr, W. Lubitz, and P. Kudela, “Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications,” Expert Review of Vaccines, vol. 11, no. 1, pp. 97–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Fürst-Ladani, H. Redl, A. Haslberger et al., “Bacterial cell envelopes (ghosts) but not S-layers activate human endothelial cells (HUVECs) through sCD14 and LBP mechanism,” Vaccine, vol. 18, no. 5-6, pp. 440–448, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Jalava, A. Hensel, M. Szostak, S. Resch, and W. Lubitz, “Bacterial ghosts as vaccine candidates for veterinary applications,” Journal of Controlled Release, vol. 85, no. 1-3, pp. 17–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. Amara, M. M. Salem-Bekhit, and F. K. Alanazi, “Sponge-Like: a new protocol for preparing bacterial ghosts,” The Scientific World Journal, vol. 2013, Article ID 545741, 7 pages, 2013. View at Publisher · View at Google Scholar
  5. A. A. Amara, M. M. Salem-Bekhit, and F. K. Alanazi, “Plackett-Burman randomization method for Bacterial Ghosts preparation form E. coli JM109,” Saudi Pharmaceutical Journal, 2013. View at Publisher · View at Google Scholar
  6. A. A. Amara, M. M. Salem-Bekhit, and F. K. Alanazi, “Preparation of Bacterial Ghosts for E. coli JM109 using “Sponge-like Reduced Protocol”,” Asian Journal of Biological Sciences, vol. 6, no. 8, pp. 363–369, 2013. View at Publisher · View at Google Scholar
  7. C. A. Hutchison III and R. L. Sinsheimer, “The process of infection with bacteriophage phi-X174. X. Mutations in a phi-X Lysis gene,” Journal of Molecular Biology, vol. 18, no. 3, pp. 429–447, 1966. View at Google Scholar · View at Scopus
  8. W. Haidinger, U. B. Mayr, M. P. Szostak, S. Resch, and W. Lubitz, “Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease,” Applied and Environmental Microbiology, vol. 69, no. 10, pp. 6106–6113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Y. Kang and R. Curtiss III, “Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization,” FEMS Immunology and Medical Microbiology, vol. 37, no. 2-3, pp. 99–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Andrews, “Determination of minimum inhibitory concentrations,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 1, pp. 5–16, 2001. View at Google Scholar · View at Scopus
  11. R. Cruickshank, Medical Microbiology, E. and S. Livingstone, London, UK, 11th edition, 1965.
  12. A. Felix and B. R. Callow, “Typing of paratyphoid B bacilli by means of VI bacteriophage: a report to the medical research council,” British Medical Bulletin, vol. 1, no. 8, p. 91, 1943. View at Google Scholar · View at Scopus
  13. P. Plackett and J. P. Burman, “The design of optimum multifactorial experiments,” Biometrika, vol. 37, pp. 305–325, 1946. View at Google Scholar
  14. University of Gothenburg, “Oral vaccine against diarrhea promising,” ScienceDaily, May 2013, http://www.sciencedaily.com/releases/2013/05/130522085215.htm. View at Google Scholar
  15. N. Lycke and J. Holmgren, “Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens,” Immunology, vol. 59, no. 2, pp. 301–308, 1986. View at Google Scholar · View at Scopus
  16. J. Holmgren, N. Lycke, and C. Czerkinsky, “Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems,” Vaccine, vol. 11, no. 12, pp. 1179–1184, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Takada and H. Kida, “Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus,” Veterinary Microbiology, vol. 50, no. 1-2, pp. 17–25, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Vervelde, E. M. Janse, A. N. Vermeulen, and S. H. M. Jeurissen, “Induction of a local and systemic immune response using cholera toxin as vehicle to deliver antigen in the lamina propria of the chicken intestine,” Veterinary Immunology and Immunopathology, vol. 62, no. 3, pp. 261–272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Girard, P. Péry, M. Naciri, and P. Quéré, “Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os,” Vaccine, vol. 17, no. 11-12, pp. 1516–1524, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. R. H. Gilman, R. B. Hornick, and W. E. Woodward, “Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a live oral vaccine,” Journal of Infectious Diseases, vol. 136, no. 6, pp. 717–723, 1977. View at Google Scholar · View at Scopus
  21. H. A. Mansour and M. G. Soliman, “Protective effect of oral and intranasal bacterial lysates in mice,” The Egyptian Journal of Hospital Medicine, vol. 3, pp. 37–56, 2003. View at Google Scholar
  22. S. L. Mayo, M. Tufvesson, H.-E. Carlsson, F. Royo, S. Gizurarson, and J. Hau, “RhinoVax is an efficient adjuvant in oral immunisation of young chickens and Cholera Toxin B is an effective oral primer in subcutaneous immunisation with Freunds's incomplete adjuvant,” In Vivo, vol. 19, no. 2, pp. 375–382, 2005. View at Google Scholar · View at Scopus